Researchers Find That Common Nutrient Could Supercharge The Immune Cells Fighting Cancer
As this approach is studied further, other exciting approaches, such as the use of oncolytic virus therapy , are also being advanced by many companies like Calidi Biotherapeutics Inc. (NYSE American: CLDI) . It is just a matter of time before these different forms of immunotherapy deliver superior clinical outcomes...
Read More>>
About BioMedWire
BioMedWire (“BMW”) is a specialized communications platform with a focus on the latest developments in the Biotechnology (BioTech), Biomedical Sciences (BioMed) and Life Sciences sectors. It is one of 70+ brands within the Dynamic Brand Portfolio @ IBN that delivers : (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries ; (2) article and editorial syndication to 5,000+ outlets ; (3) enhanced press release enhancement to ensure maximum impact ; (4) social media distribution via IBN to millions of social media followers ; and (5) a full array of tailored corporate communications solutions . With broad reach and a seasoned team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today's market, BMW brings its clients unparalleled recognition and brand awareness.
BMW is where breaking news, insightful content and actionable information converge.
To receive SMS alerts from BioMedWire,“Biotech” to 888-902-4192 (U.S. Mobile Phones Only)
For more information, please visit
Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: /Disclaimer
BioMedWire
San Francisco, CA
415.949.5050 Office
[email protected]
BioMedWire is powered by IBN
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.
Most popular stories
Market Research

- Zebu Live 2025 Welcomes Coinbase, Solana, And Other Leaders Together For UK's Biggest Web3 Summit
- Yield Basis Nears Mainnet Launch As Curve DAO Votes On Crvusd Proposal
- Blueberry Launches A Bold New Brand Platform
- Stonehaven Circle Marks 13Th Anniversary With Hadrian Colwyn Leading Calvio Ailegacyx Innovation
- R0AR Launches Buyback Vault: Bringing 1R0R To R0AR Chain Unlocks New Incentives
- Moonbirds And Azuki IP Coming To Verse8 As AI-Native Game Platform Integrates With Story
Comments
No comment